Peripheral immune signatures and survival in stage IV melanoma

被引：0
|
作者：
Pawelec, Graham P. [1 ]
Martens, Alexander [1 ]
Garbe, Claus [1 ]
Weide, Benjamin [1 ]
Derhovanessian, Evelyna [1 ]
Schadendorf, Dirk [2 ]
Di Giacomo, Anna Maria [3 ]
Maio, Michele [3 ]
de Vries, Jolanda [4 ]
Zelba, Henning [1 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Univ Essen Gesamthsch, Essen, Germany
[3] Univ Siena, I-53100 Siena, Italy
[4] Univ Nijmegen, Nijmegen, Netherlands
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2547
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2547
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
    Jamal, Rahima
    Lapointe, Rejean
    Cocolakis, Eftihia
    Thebault, Pamela
    Kazemi, Shirin
    Friedmann, Jennifer E.
    Dionne, Jeanne
    Cailhier, Jean-Francois
    Belanger, Karl
    Ayoub, Jean-Pierre
    Le, Huy
    Lambert, Caroline
    El-Hajjar, Jida
    van Kempen, Leon C.
    Spatz, Alan
    Miller, Wilson H., Jr.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [2] Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients
    Wistuba-Hamprecht, Kilian
    Martens, Alexander
    Weide, Benjamin
    Teng, Karen Wei Weng
    Zelba, Henning
    Guffart, Elena
    Chen, Jinmiao
    Garbe, Claus
    Newell, Evan William
    Larbi, Anis
    Pawelec, Graham
    JOURNAL OF IMMUNOLOGY, 2017, 198 (02): : 927 - 936
  • [3] Survival of stage IV melanoma in Belgium and the Netherlands
    Suijkerbuijk, K. P. M.
    Haanen, J. B. A. G.
    Boers-Sonderen, M. J.
    Hospers, G. A. P.
    Blank, C. U.
    vanden Berkmortel, F. W. P. J.
    deGroot, J. W. B.
    Piersma, D.
    Aarts, M. J. B.
    van Rijn, R. S.
    Vreugdenhil, G.
    Westgeest, H. M.
    Kapiteijn, E.
    van derVeldt, A. A. M.
    vanden Eertwegh, A. J. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (02) : E118 - E119
  • [4] Preoperative peripheral blood lymphocyte/monocyte ratio and survival in patients with resected stage IV melanoma
    Rochet, Nicole M.
    Porrata, Luis F.
    Kottschade, Lisa A.
    Grotz, Travis Edward
    Markovic, Svetomir
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Variates of survival for stage IV uveal melanoma.
    Rietschel, P
    Panageas, K
    Hanlon, C
    Patel, A
    Chapman, PB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 719S - 719S
  • [6] Can surgeons improve survival in stage IV melanoma?
    Mosca, Paul J.
    Teicher, Erik
    Nair, Suresh P.
    Pockaj, Barbara A.
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (05) : 462 - 468
  • [7] Immune Signatures for the Response and Occurrence of immune-mediated Side Effects under Immune Checkpoint Inhibitor Therapy in Stage IV Melanoma Patients
    Reschke, R.
    Gussek, P.
    Boldt, A.
    Sack, U.
    Koehl, U.
    Lordick, F.
    Kreuz, M.
    Reiche, K.
    Simon, J. C.
    Ziemer, M.
    Kunz, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 7 - 8
  • [8] Immune gene polymorphisms predict overall survival for stage IV melanoma patients treated with biochemotherapy.
    Liu, D
    O'Day, SJ
    Yang, D
    Boasberg, P
    Milford, R
    Kristedja, T
    Groshen, S
    Weber, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 722S - 722S
  • [9] Immune Inhibitor Combination Prolongs Recurrence-Free Survival in Stage IV Melanoma with no Evidence of Disease
    Schwarz, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (11) : 2098 - 2098
  • [10] Long term Survival in stage IV melanoma after Electrochemotherapy
    Boettjer, Joerg
    Stadler, Rudolph
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 683 - 683
12345